Streetbeat News

Products Services

WKSP

Worksport has announced the anticipated summer launch of its SOLIS Solar Cover and COR Battery System, marking a significant step forward in its product offerings.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 10:16 pm

SHIBUSD

Shiba Inu (SHIB) has seen a 1.7% increase in the past 24 hours, maintaining its top 10 market cap position. Lead developer Shytoshi Kusama hinted at upcoming Shiba Inu-themed services. A significant token burn of 177 million tokens, including a single transaction of 100.5 million tokens, coincides with the coin's price recovery. Technical analyst Javon Marks predicts a potential 120% price increase for SHIB. Increased transactions over $100,000 and new account registrations on Shibarium Scan suggest growing investor interest.

Portfolio Pulse from Khyathi Dalal

March 06, 2024 | 10:13 pm

EBS

Emergent BioSolutions Inc (NYSE:EBS) reported Q4 losses of 77 cents per share, missing analyst estimates, and quarterly sales of $276.6 million, below expectations. Sales from Narcan Nasal Spray increased by 22% year-over-year. The company amended its credit agreement for more flexible terms and provided an optimistic revenue outlook for Q1 and the fiscal year, despite acknowledging short-term challenges.

Portfolio Pulse from Erica Kollmann

March 06, 2024 | 10:02 pm

GSK

PFE

ViiV Healthcare, majorly owned by GSK with Pfizer and Shionogi as shareholders, announced interim phase 3 trial results showing its injectable HIV treatment, Cabenuva, outperforms daily oral therapy in maintaining viral suppression in patients with ART adherence challenges. The study highlighted superior efficacy of the long-acting injectable over standard oral care, despite similar rates of adverse events. Pfizer's stock saw a 4.26% increase to $27.19 following the news.

Portfolio Pulse from Vandana Singh

March 06, 2024 | 10:00 pm

LYT

Lytus Technologies' stock price increased following the announcement of the launch of Lytus Cloud, indicating positive market reception to the company's new service offering.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 9:55 pm

QDEL

QuidelOrtho has received Health Canada approval for its Quidel Triage PLGF test, designed for laboratory use in Canada. This approval marks a significant milestone for the company, allowing it to expand its product offerings in the Canadian healthcare market.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 9:50 pm

BTCUSD

10x Research analyzed Bitcoin's recent liquidation crash and remains bullish despite expecting a short-term sideways market. The firm's model, showing a high volatility signal, suggests three scenarios based on Bitcoin's price action, with strong ETF inflows noted even amid the price drop. The analysis is based on patterns from the past decade and current positioning above the 100-day moving average.

Portfolio Pulse from Khyathi Dalal

March 06, 2024 | 9:50 pm

LYT

Lytus Technologies has announced the launch of its new Lytus Cloud Infrastructure Services, marking a significant expansion of its product offerings.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 9:46 pm

SPRC

SciSparc has been granted a Canadian patent for its technology aimed at reducing opioid use in pain management. This development could position SciSparc as a key player in the pain management sector, potentially impacting its market value and investor interest.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 9:45 pm

YEXT

Yext, Inc. (NYSE:YEXT) reported Q4 earnings of 10 cents per share, surpassing the 7 cents estimate and marking a 100% increase year-over-year. Q4 sales were $101.1 million, beating the $100.62 million estimate. The company highlighted its highest Direct Sales productivity in four years and a doubling in North America Enterprise Sales year-over-year. Yext's outlook for Q1 includes expected revenue of $96-$96.5 million, below the $99.783 million estimate, and adjusted earnings of 4-5 cents per share. For fiscal year 2025, Yext forecasts revenue of $400-$402 million and adjusted earnings of 30-31 cents per share, with new product releases anticipated in the second half of the year. Yext shares surged 17.3% in after-hours trading to $6.98.

Portfolio Pulse from Erica Kollmann

March 06, 2024 | 9:34 pm